OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients

Transplant Proc. 1994 Feb;26(1):154-6.

Authors

J F Sommerauer¹, P Atkison, J Howard, D Grant, W Wall

Affiliation

¹ Department of Pediatrics and Surgery, University and Children's Hospital of Western Ontario, London, Canada.

PMID: 8108917

No abstract available

Publication types

Clinical Trial

MeSH terms

Adolescent
Antilymphocyte Serum / therapeutic use
Child
Child, Preschool
Female
Graft Rejection / drug therapy
Graft Rejection / prevention & control
Graft Rejection / therapy
Humans
Immunosuppression Therapy / methods*
Infant
Liver Transplantation / adverse effects
Liver Transplantation / immunology*
Male
Methylprednisolone / therapeutic use
Muromonab-CD3 / adverse effects
Muromonab-CD3 / blood
Muromonab-CD3 / pharmacology*
T-Lymphocyte Subsets / immunology

Substances

Antilymphocyte Serum
Muromonab-CD3
Methylprednisolone